245 related articles for article (PubMed ID: 19304434)
1. Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.
Pérez-Grande R; Gutiérrez-Zufiaurre N; Muñoz-Criado S; Blázquez de Castro AM; Vázquez López L; González San Martín F; García Rodríguez JA; Muñoz Bellido JL
Diagn Microbiol Infect Dis; 2009 May; 64(1):80-2. PubMed ID: 19304434
[TBL] [Abstract][Full Text] [Related]
2. Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
Hashino S; Nozawa A; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Hige S; Asaka M
Bone Marrow Transplant; 2002 Feb; 29(4):361-3. PubMed ID: 11896435
[TBL] [Abstract][Full Text] [Related]
3. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
[TBL] [Abstract][Full Text] [Related]
4. Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients?
Orlando R; Tosone G; Tiseo D; Piazza M; Portella G; Ciancia R; Martinelli V; Montante B; Rotoli B
Infection; 2006 Oct; 34(5):282-4. PubMed ID: 17033754
[TBL] [Abstract][Full Text] [Related]
5. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
Uhm JE; Kim K; Lim TK; Park BB; Park S; Hong YS; Lee SC; Hwang IG; Koh KC; Lee MH; Ahn JS; Kim WS; Jung CW; Kang WK
Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.
Kempinska A; Kwak EJ; Angel JB
Clin Infect Dis; 2005 Nov; 41(9):1277-82. PubMed ID: 16206102
[TBL] [Abstract][Full Text] [Related]
7. [Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
Sugimoto R; Enjoji M; Kotoh K; Noguchi K; Tsuruta S; Nakamuta M; Nawata H
Fukuoka Igaku Zasshi; 2004 Oct; 95(10):274-9. PubMed ID: 15678886
[TBL] [Abstract][Full Text] [Related]
8. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
Knöll A; Boehm S; Hahn J; Holler E; Jilg W
J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia].
Lim SM; Jang JW; Kim BW; Choi H; Choi KY; Park SJ; Han CW
Korean J Hepatol; 2008 Jun; 14(2):213-8. PubMed ID: 18617769
[TBL] [Abstract][Full Text] [Related]
10. Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation.
Picardi M; Selleri C; De Rosa G; Raiola A; Pezzullo L; Rotoli B
Bone Marrow Transplant; 1998 Jun; 21(12):1267-9. PubMed ID: 9674862
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudine-resistant HBV reactivation following hepatitis B surface antigen seroconversion.
Gérolami R; Borentain P; Colson P; Norguet E; Gérolami A; Tamalet C
Liver Int; 2007 Dec; 27(10):1417-21. PubMed ID: 18036104
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
Ahn HJ; Kim MS; Kim YS; Kim SI; Huh KH; Ju MK; Ahn SH; Han KH
J Med Virol; 2007 Nov; 79(11):1655-63. PubMed ID: 17854044
[TBL] [Abstract][Full Text] [Related]
13. High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
Matsue K; Aoki T; Odawara J; Fujiwara H; Iwama K; Kimura S; Yamakura M; Takeuch M
Eur J Haematol; 2009 Oct; 83(4):357-64. PubMed ID: 19508685
[TBL] [Abstract][Full Text] [Related]
14. Changes in serological markers of hepatitis B virus after renal transplantation.
Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
[TBL] [Abstract][Full Text] [Related]
15. Treatment induced seroconversion to HBsAb following HBV reactivation in the immunosuppressed haematology and oncology patient: a clinical survey of 5 cases in Catania, Italy.
Montineri A; Nigro L; La Rosa R; Iacobello C; Larocca L; Cappello E; Fiumara PF; Di Raimondo F; Fatuzzo F
J Clin Virol; 2011 Dec; 52(4):284-7. PubMed ID: 21906994
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B].
Kim JM; Choe BH; Chu MA; Cho SM
Korean J Hepatol; 2009 Jun; 15(2):168-78. PubMed ID: 19581769
[TBL] [Abstract][Full Text] [Related]
17. Histological improvement with lamivudine therapy for de novo hepatitis B occurring in an anti-HBs-positive child after bone marrow transplantation.
Yeung LT; Petric M; Cutz E; Roberts EA
Bone Marrow Transplant; 2002 Oct; 30(7):459-62. PubMed ID: 12368959
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously cured of hepatitis B].
Romand F; Michallet M; Pichoud C; Trépo C; Zoulim F
Gastroenterol Clin Biol; 1999; 23(6-7):770-4. PubMed ID: 10470533
[TBL] [Abstract][Full Text] [Related]
19. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period.
Iwai K; Tashima M; Itoh M; Okazaki T; Yamamoto K; Ohno H; Marusawa H; Ueda Y; Nakamura T; Chiba T; Uchiyama T
Bone Marrow Transplant; 2000 Jan; 25(1):105-8. PubMed ID: 10654023
[TBL] [Abstract][Full Text] [Related]
20. Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.
Akalin E; Ames S; Sehgal V; Murphy B; Bromberg JS
Clin Transplant; 2005 Jun; 19(3):364-6. PubMed ID: 15877799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
